NO902961L - Fremgangsmaate for fremstilling av lav-viskoese, hoeykonsentrerte suspensjoner av overflateaktive stoffer. - Google Patents

Fremgangsmaate for fremstilling av lav-viskoese, hoeykonsentrerte suspensjoner av overflateaktive stoffer.

Info

Publication number
NO902961L
NO902961L NO90902961A NO902961A NO902961L NO 902961 L NO902961 L NO 902961L NO 90902961 A NO90902961 A NO 90902961A NO 902961 A NO902961 A NO 902961A NO 902961 L NO902961 L NO 902961L
Authority
NO
Norway
Prior art keywords
viscose
procedure
preparation
low
active substances
Prior art date
Application number
NO90902961A
Other languages
English (en)
Other versions
NO902961D0 (no
NO180620C (no
NO180620B (no
Inventor
Bernd Disse
Eberhard Weller
Robert Becker
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO902961D0 publication Critical patent/NO902961D0/no
Publication of NO902961L publication Critical patent/NO902961L/no
Publication of NO180620B publication Critical patent/NO180620B/no
Publication of NO180620C publication Critical patent/NO180620C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Artificial Filaments (AREA)
  • Colloid Chemistry (AREA)
NO902961A 1989-07-04 1990-07-03 Fremgangsmåte for fremstilling av surfaktantsuspensjoner for substitusjonsterapi ved luftveissykdommer NO180620C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3921954A DE3921954A1 (de) 1989-07-04 1989-07-04 Niedrig-viskose, hochkonzentrierte surfactant-suspension

Publications (4)

Publication Number Publication Date
NO902961D0 NO902961D0 (no) 1990-07-03
NO902961L true NO902961L (no) 1991-01-07
NO180620B NO180620B (no) 1997-02-10
NO180620C NO180620C (no) 1997-05-21

Family

ID=6384269

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902961A NO180620C (no) 1989-07-04 1990-07-03 Fremgangsmåte for fremstilling av surfaktantsuspensjoner for substitusjonsterapi ved luftveissykdommer

Country Status (24)

Country Link
US (1) US5552161A (no)
EP (1) EP0406732B1 (no)
JP (1) JP3103582B2 (no)
KR (1) KR0162642B1 (no)
AT (1) ATE122891T1 (no)
AU (1) AU623538B2 (no)
CA (1) CA2020209C (no)
DD (1) DD297916A5 (no)
DE (2) DE3921954A1 (no)
DK (1) DK0406732T3 (no)
ES (1) ES2072940T3 (no)
FI (1) FI95655C (no)
HK (1) HK1000277A1 (no)
HU (1) HU205004B (no)
IE (1) IE68448B1 (no)
IL (1) IL94961A (no)
NO (1) NO180620C (no)
NZ (2) NZ234341A (no)
PH (1) PH30232A (no)
PL (1) PL164434B1 (no)
PT (1) PT94574B (no)
RU (1) RU2077880C1 (no)
UA (1) UA26313A (no)
ZA (1) ZA905182B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
WO2001019392A1 (en) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
EP1249244A1 (en) * 2001-04-13 2002-10-16 Universiteit Gent Therapeutic compositions for the treatment of a disease modulated by the G-actin / F-actin equilibrium, especially a respiratory tract disease
AU2002338882B2 (en) 2001-10-11 2008-04-03 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Novel use of pulmonary surfactant
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
KR101243867B1 (ko) 2005-05-11 2013-03-20 야마사 쇼유 가부시키가이샤 폐서팩턴트 단백질의 안정화법
US8048043B2 (en) * 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
EP0110498B2 (en) * 1982-11-22 1991-09-18 Teijin Limited Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
CS938384A1 (en) * 1983-12-08 1990-08-14 Lachmann Burkhardt Pharmaceutical agent for breathlesness therapy and method of its production
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e

Also Published As

Publication number Publication date
NO902961D0 (no) 1990-07-03
DE59009113D1 (de) 1995-06-29
PL164434B1 (pl) 1994-07-29
IL94961A0 (en) 1991-06-10
ZA905182B (en) 1992-03-25
EP0406732B1 (de) 1995-05-24
NO180620C (no) 1997-05-21
EP0406732A3 (en) 1991-02-27
IE68448B1 (en) 1996-06-26
HUT56274A (en) 1991-08-28
DD297916A5 (de) 1992-01-30
ATE122891T1 (de) 1995-06-15
HK1000277A1 (en) 1998-02-20
IE902408A1 (en) 1991-06-19
EP0406732A2 (de) 1991-01-09
CA2020209A1 (en) 1991-01-05
PT94574A (pt) 1991-03-20
NZ242869A (en) 1997-05-26
DK0406732T3 (da) 1995-10-02
HU205004B (en) 1992-03-30
FI95655C (fi) 1996-03-11
JPH0344332A (ja) 1991-02-26
CA2020209C (en) 2000-09-12
AU5867690A (en) 1991-01-10
HU904077D0 (en) 1990-12-28
RU2077880C1 (ru) 1997-04-27
NZ234341A (en) 1992-07-28
KR0162642B1 (ko) 1998-12-01
NO180620B (no) 1997-02-10
ES2072940T3 (es) 1995-08-01
US5552161A (en) 1996-09-03
UA26313A (uk) 1999-08-30
DE3921954A1 (de) 1991-01-17
FI95655B (fi) 1995-11-30
AU623538B2 (en) 1992-05-14
FI903341A0 (fi) 1990-07-03
IL94961A (en) 1994-10-21
PT94574B (pt) 1997-02-28
JP3103582B2 (ja) 2000-10-30
KR910002427A (ko) 1991-02-25
PH30232A (en) 1997-02-05

Similar Documents

Publication Publication Date Title
EP0406998A3 (en) Use of phospholipids in lung surfactant replacement therapy
NO306655B1 (no) Anvendelse av GLA, DGLA eller LA ved fremstilling av et medisinsk preparat
GB2276086A (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
YU209288A (en) Process for producing compound for treating, which contains azelastin for use in nose and/or eye
MX169329B (es) Composicion con bajo contenido de sal de sodio y metodo para su preparacion
FI941245A (fi) Menetelmä 2'-deoksiguanosiinin asyylijohdannaisten valmistamiseksi
NO902961D0 (no) Fremgangsmaate for fremstilling av lav-viskoese, hoeykonsentrerte suspensjoner av overflateaktive stoffer.
PH21102A (en) Improvements in or relating to benzothiophene derivatives as antiastmatic agents
PT87796A (pt) Process for the preparation of biocide compounds for the treatment of air in systems of air-conditioned
NO174677C (no) Fremgangsmåte ved fremstilling av en defklokkulert kalsiumkarbonatsuspensjon, og anvendelse av denne
EP0285856A3 (en) Use of dihydroergotamine and its salts in the local treatment of trophic disorders
EP0437026A3 (en) Use of tandospirone in the treatment of depression
GR3006674T3 (no)
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
GB2314271A (en) Therapeutic methods and preparations using rubidium ions
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб
HRP970171A2 (en) Use of bradykinin antagonists for the preparation of medicaments to treat chronic fibrogenetic liver disease and acute liver disease
FR2527630B1 (fr) Enzyme leucocytaire humaine de type pepsique, procede pour sa preparation et agent therapeutique la contenant
RU97117568A (ru) Гастропульмин
GB9010190D0 (en) Composition for the treatment of protozoal disease and their use
BG102009A (en) Method for the treatment of manic and two-pole disease
ES2060153T3 (es) Composicion terapeutica y cajita para el tratamiento de la poliartritis reumatoide.
RU94016980A (ru) Энтеросорбент для терапии почечной недостаточности
MA19564A1 (fr) Derives de la pyrrolidine, sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale
GB8922012D0 (en) Composition for treatment of respiratory ailments